Rapamycin Antagonizes BCRP-Mediated Drug Resistance Through the PI3K/Akt/mTOR Signaling Pathway in mPRα-Positive Breast Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapamycin Antagonizes BCRP-Mediated Drug Resistance Through the PI3K/Akt/mTOR Signaling Pathway in mPRα-Positive Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-12
DOI
10.3389/fonc.2021.608570
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12
- (2018) Jing Hu et al. Translational Oncology
- Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors
- (2016) Monica Salazar et al. GENE
- Breast Cancer Invasion and Metastasis by mPRα Through the PI3K/Akt Signaling Pathway
- (2015) Xiaojuan Wu et al. PATHOLOGY & ONCOLOGY RESEARCH
- Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer
- (2015) J. Thaddeus Beck OncoTargets and Therapy
- Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines
- (2015) Maricla Galetti et al. PLoS One
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Progesterone Negatively Regulates BCRP in Progesterone Receptor-Positive Human Breast Cancer Cells
- (2013) Xiaojuan Wu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer
- (2012) Xiaojuan Wu et al. CANCER SCIENCE
- Characterization, Neurosteroid Binding and Brain Distribution of Human Membrane Progesterone Receptors δ and ϵ (mPRδ and mPRϵ) and mPRδ Involvement in Neurosteroid Inhibition of Apoptosis
- (2012) Yefei Pang et al. ENDOCRINOLOGY
- Membrane Progesterone Receptor Alpha as a Potential Prognostic Biomarker for Breast Cancer Survival: A Retrospective Study
- (2012) Mingxuan Xie et al. PLoS One
- MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells
- (2011) Xiaofang Zhang et al. JOURNAL OF SURGICAL ONCOLOGY
- Broad tissue expression of membrane progesterone receptor Alpha in normal mice
- (2010) Shaojin You et al. JOURNAL OF MOLECULAR HISTOLOGY
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
- (2010) Sunil Badve et al. MODERN PATHOLOGY
- Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer
- (2010) T Sato et al. ONCOGENE
- Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells
- (2009) Yuhua Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies
- (2009) David T. Teachey et al. BRITISH JOURNAL OF HAEMATOLOGY
- Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy
- (2008) Kohji Noguchi et al. ADVANCED DRUG DELIVERY REVIEWS
- Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice
- (2008) Maria L.H. Vlaming et al. ADVANCED DRUG DELIVERY REVIEWS
- ABCG2: A perspective
- (2008) Robert W. Robey et al. ADVANCED DRUG DELIVERY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now